These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1908729)

  • 1. Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) reduces infection-related mortality after allogeneic T-cell depleted BMT.
    De Witte T; Gratwohl A; Van der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE
    Bone Marrow Transplant; 1991; 7 Suppl 2():83. PubMed ID: 1908729
    [No Abstract]   [Full Text] [Related]  

  • 2. RHU GM-CSF shortens aplasia duration after ABMT in non-Hodgkin's lymphoma: a randomized placebo-controlled double-blind study.
    Gorin NC; Coiffier B; Hayat M; Philip T; Vernant JP; Hervé P; Colombat P; Boivin P; Slavin S; Eugène-Jolchine I
    Bone Marrow Transplant; 1991; 7 Suppl 2():82. PubMed ID: 1878733
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of GM-CSF as an adjunct to autologous/syngeneic bone marrow transplantation: a prospective randomized controlled trial.
    Visani G; Gamberi B; Greenberg P; Advani R; Gulati S; Champlin R; Hoglund M; Karanes C; Williams S; Keating A
    Bone Marrow Transplant; 1991; 7 Suppl 2():81. PubMed ID: 1878732
    [No Abstract]   [Full Text] [Related]  

  • 4. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.
    Nemunaitis J; Rosenfeld CS; Ash R; Freedman MH; Deeg HJ; Appelbaum F; Singer JW; Flomenberg N; Dalton W; Elfenbein GJ
    Bone Marrow Transplant; 1995 Jun; 15(6):949-54. PubMed ID: 7581096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human recombinant GM-CSF in allogeneic bone marrow transplantation for leukaemia: double-blind placebo controlled trial.
    Powles R; Treleaven J; Millar J; Gordon-Smith EC; Tiley C; Findlay M; Teo C; Duncombe A; Robinson G
    Bone Marrow Transplant; 1991; 7 Suppl 2():85-6. PubMed ID: 1878735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean myeloperoxidase index in lymphoma transplants receiving recombinant granulocyte-macrophage colony stimulating factor.
    Tsakona CP; Khwaja A; Goldstone AH
    Bone Marrow Transplant; 1993 Apr; 11(4):345-6. PubMed ID: 8387371
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF) in cyclic neutropenia.
    Locatelli F; Pedrazzoli P; Zecca M; Maccario R; Giorgiani G; Prete L; Nespoli L; Severi F
    Haematologica; 1991; 76(3):238-9. PubMed ID: 1743595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged administration of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) after T-cell-depleted allogeneic bone marrow transplantation.
    De Witte T; Vreugdenhil G; Schattenberg A
    Transplant Proc; 1993 Aug; 25(4 Suppl 3):57-60. PubMed ID: 8351721
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
    Martin-Algarra S; Bishop MR; Tarantolo S; Cowles MK; Reed E; Anderson JR; Vose JM; Bierman P; Armitage JO; Kessinger A
    Exp Hematol; 1995 Dec; 23(14):1503-8. PubMed ID: 8542938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell-depleted bone marrow transplantation.
    De Witte T; Gratwohl A; Van Der Lely N; Bacigalupo A; Stern AC; Speck B; Schattenberg A; Nissen C; Gluckman E; Fibbe WE
    Blood; 1992 Mar; 79(5):1359-65. PubMed ID: 1536959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of granulocyte-macrophage colony-stimulating factor in bone marrow transplantation.
    Armitage JO
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):14-8. PubMed ID: 1362821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation in children with acute myelogenous leukemia: a note of caution.
    Calderwood S; Doyle JJ; Hitzler JK; Saunders EF; Freedman MH
    Bone Marrow Transplant; 1996 Jul; 18(1):87-91. PubMed ID: 8832000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
    Klingemann HG; Eaves AC; Barnett MJ; Reece DE; Shepherd JD; Belch AR; Brandwein JM; Langleben A; Koch PA; Phillips GL
    Clin Invest Med; 1990 Apr; 13(2):77-81. PubMed ID: 2191816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. rhGM-CSF after allogeneic bone marrow transplantation from unrelated donors: a pilot study of cyclosporine and prednisone as graft-versus-host disease prophylaxis.
    Nemunaitis J; Anasetti C; Bianco JA; Hasen J; Singer JW
    Leuk Lymphoma; 1993 Jun; 10(3):177-81. PubMed ID: 8220115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
    Schuening FG; Storb R; Goehle S; Nash R; Graham TC; Appelbaum FR; Hackman R; Sandmaier BM; Urdal DL
    Exp Hematol; 1989 Sep; 17(8):889-94. PubMed ID: 2670596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.
    Nemunaitis J; Rabinowe SN; Singer JW; Bierman PJ; Vose JM; Freedman AS; Onetto N; Gillis S; Oette D; Gold M
    N Engl J Med; 1991 Jun; 324(25):1773-8. PubMed ID: 1903847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum colony stimulating factors in patients undergoing bone marrow transplantation: enhancing effect of recombinant human GM-CSF.
    Geissler D; Niederwieser D; Aulitzky WE; Tilg H; Grünewald K; Huber C; Konwalinka G
    Behring Inst Mitt; 1988 Aug; (83):289-300. PubMed ID: 3071343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.